Skip to content

Avantor AVTR Free cash flow

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
Danaher logo
DanaherDHR
$1.09B+2.9%
Agilent Technologies logo
Agilent TechnologiesA
$201M+87.9%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Element Solutions logo
Element SolutionsESI
Westlake logo
WestlakeWLK

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Calculated from Avantor’s reported figures.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's free cash flow?
Avantor (AVTR) reported free cash flow of $25.2M in Q1 2026.
How has Avantor's free cash flow changed year-over-year?
Avantor's free cash flow decreased by 69.0% year-over-year, from $81.3M to $25.2M.
What is the long-term trend for Avantor's free cash flow?
Over 4 years (2021 to 2025), Avantor's free cash flow has grown at a -12.4% compound annual growth rate (CAGR), from $842.5M to $495M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.